The role of neurotrophins related to stress in saliva and salivary glands

Histology and Histopathology

Volumn 25, Issue 10, 2010, Pages 1317-1330

  Saruta, Juri ^a   Sato, Sadao ^a   Tsukinoki, Keiichi ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

Brain derived neurotrophic factor (BDNF); Neurotrophins; Saliva; Salivary gland; Stress

Indexed keywords

RATTUS;

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NERVE GROWTH FACTOR;

ANIMAL; BLOOD; DISEASE MODEL; EXERCISE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; MENTAL STRESS; METABOLISM; RAT; REVIEW; SALIVA; SALIVARY GLAND; TIME;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; MALE; NERVE GROWTH FACTORS; RATS; RECEPTOR, TRKB; RESTRAINT, PHYSICAL; SALIVA; SALIVARY GLANDS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 78650847528     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Adlard P.A. and Cotman C.W. (2004). Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience 124, 985-992.
2. Alleva E. and Francia N. (2009). Psychiatric vulnerability: suggestions from animal models and role of neurotrophins. Neurosci. Biobehav. Rev. 33, 525-536.
3. Aloe L., Alleva E., Bohm A. and Levi-Montalcini R. (1986). Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc. Natl. Acad. Sci. USA 83, 6184-6187.
4. Aloe L., Alleva E., Bohm A. and De Simone R. (1990). Change of NGF level in mouse hypothalamus following intermale aggressive behaviour: biological and immunohistochemical evidence. Behav. Brain. Res. 39, 53-61.
5. Aloe L., Bracci-Laudiero L., Alleva E., Lambiase A., Micera A. and Tirassa P. (1994). Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc. Natl. Acad. Sci. USA 91, 10440-10444.
6. Altar C.A. and DiStefano P.S. (1998). Neurotrophin trafficking by anterograde transport. Trends. Neurosci. 21, 433-437.
7. Altar C.A., Siuciak J.P., Wright P., Ip N.Y., Lindsay R.M. and Wiegand S.J. (1994). In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF, [125I]NT-4/5 and [125I]NT-3. Eur. J. Neurosci. 6, 1389-1405.
8. Amano O. and Iseki S. (1998). Occurrence and nuclear localization of cAMP response element-binding protein in the postnatal development of the rat submandibular gland. Histochem. J. 30, 591- 601.
9. Barde Y.A. (1990). The nerve growth factor family. Prog. Growth. Factor. Res. 2, 237-248.
10. Barde Y.A., Edgar D. and Thoenen H. (1982). Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1, 549-553.
11. Begliuomini S., Lenzi E., Ninni F., Casarosa E., Merlini S., Pluchino N., Valentino V., Luisi M., Luisi M. and Genazzani A.R. (2008). Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J. Endocrinol. 197, 429-435.
12. Benedetti F., Barbini B., Colombo C. and Smeraldi E. (2007). Chronotherapeutics in a psychiatric ward. Sleep Med. Rev. 11, 509-522.
13. Bersani G., Iannitelli A., Maselli P., Pancheri P., Aloe L., Angelucci F. and Alleva E. (1999). Low nerve growth factor plasma levels in schizophrenic patients: a preliminary study. Schizophr. Res. 37, 201-203.
14. Bersani G., Iannitelli A., Massoni E., Garavini A., Grilli A., Di Giannantonio M., Conti C.M. and Pancheri P. (2004). Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects. Int. J. Immunopathol. Pharmacol. 17, 362-372.
15. Bodner L. (1991). Effect of parotid submandibular and sublingual saliva on wound healing in rats. Comp. Biochem. Physiol. A. Comp. Physiol. 100, 887-890.
16. Bradley R.M. (1995). Salivary secretion. In: Essentials of oral physiology. Mosby. St. Louis. pp 161-186.
17. Braun A., Lommatzsch M., Neuhaus-Steinmatz U., Quarcoo D., Glaab T., McGregor G.P., Fischer A. and Renz H. (2004). Brain-derived neurotrophic factor (BDNF) contributes to neuronal dysfunction in a model of allergic airway inflammation. Br. J. Pharmacol. 141, 431-440.
18. Brown M.R. and Fisher L.A. (1984). Brain peptide regulation of adrenal epinephrine secretion. Am. J. Physiol. 247, E41-E46.
19. Cassiman D., Denef C., Desmet V.J. and Roskams T. (2001). Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 33, 148-158.
20. Castren E. (2004). Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol. Neurobiol. 29, 289-302.
21. Chretien M. (1977). Action of testosterone on the differentiation and secretary activity of a target origin: The submandibular gland of the mouse. Int. Rev. Cytol. 50, 333-396.
22. Cirulli F. and Alleva E. (2009a). The NGF saga: from animal models of psychosocial stress to stress-related psychopathology. Front. Neuroendocrinol. 30, 379-395.
23. Cirulli F., Francia N., Berry A., Aloe L., Alleva E. and Suomi S.J. (2009b). Early life stress as a risk factor for mental health: role of neurotrophins from rodents to non-human primates. Neurosci. Biobehav. Rev. 33, 573-585.
24. Cohen S. (1960). Purification of nerve-growth promoting protein from the mouse salivary gland and its neuro-cytotoxic antiserum. Proc. Natl. Acad. Sci. USA 46, 302-311.
25. Cohen S. (1962). Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newly born animal. J. Biol. Chem. 237, 1555-1562.
26. Costigen D.C., Guyda H.J. and Posner B.I. (1988). Free insulin-like growth factor I (IGF-I) and IGF-II in human saliva. J. Clin. Endocrinol. Metab. 66, 1014-1018.
27. Dagogo-Jack S., Atkinson S. and Kendall-Taylor P. (1985). Homologous radioimmunoassay for epidermal growth factor in human saliva. J. Immunoassay 6, 125-136.
28. Dardick I., Byard R.W. and Carnegie J.A. (1990). A review of the proliferative capacity of major salivary glands and the relationship to current concepts of neoplasia in salivary glands. Oral Surg. Oral Med. Oral Pathol. 69, 53-67.
29. Denny P., Hagen F.K., Hardt M., Liao L., Yan W., Arellanno M., Bassilian S., Bedi G.S., Boontheung P., Cociorva D., Delahunty C.M., Denny T., Dunsmore J., Faull K.F., Gilligan J., Gonzalez- Begne M., Halgand F., Hall S.C., Han X., Henson B., Hewel J., Hu S., Jeffrey S., Jiang J., Loo J.A., Ogorzalek Loo R.R., Malamud D., Melvin J.E., Miroshnychenko O., Navazesh M., Niles R., Park S.K., Prakobphol A., Ramachandran P., Richert M., Robirison S., Sondej M., Souda P., Sullivan M.A., Takashima J., Than S., Wang J., Whitelegge J.P., Witkowska H.E., Wolinsky L., Xie Y., Xu T., Yu W., Ytterberg J., Wong D.T., Yates J.R. 3rd and Fisher S.J. (2008). The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J. Proteome Res. 7, 1994-2006.
30. De Vincente J.C., Garcia-Suárez O., Esteban I., Santamaria J. and Vega J.A. (1998). Immunohistochemical localization of neurotrophins and neurotrophin receptors in human and mouse salivary glands. Ann. Anat. 180, 157-163.
31. Doel J.J., Hector M.P., Amirtham C.V., Al-Anzam L.A., Benjamin N. and Allaker R.P. (2004). Protective effect of salivary nitrate and microbial nitrate reductase activity against caries. Eur. J. Oral. Sci. 112, 424-428.
32. Duman R.S., Heninger G.R. and Nestler E.J. (1997). A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54, 597-606.
33. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B. and Weinberger D.R. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
34. Ernfors P., Wetmore C., Olson L. and Persson H. (1990). Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron 5, 511-526.
35. Field R.B., Dromy R. and Hand A.R. (1987). Regulation of secretion of enzymes from von Ebner's gland of rat tongue. J. Dent. Res. 66, 586-587.
36. Fischer H.P., Eich W. and Russell I.J. (1998). Possible role for saliva as a diagnostic fluid in patients with chronic pain. Semin. Arthritis Rheum. 27, 348-359.
37. Garrett J.R., Suleiman A.M., Anderson L.C. and Proctor G.B. (1991). Secretory responses in granular ducts and acini of submandibular glands in vivo to parasympathetic or sympathetic nerve stimulation in rats. Cell Tissue Res. 264, 117-126.
38. Ghinelli E., Johansson J., Rios J.D., Chen L.L., Zoukhrin D., Hodges R.R. and Dartt D.A. (2003). Presence and localization of neurotrophins and neurotrophin receptors in rat lacrimal gland. Invest. Opthalmol. Vis. Sci. 44, 3352-3357.
39. Ghosh A., Carnahan J. and Greenberg M.E. (1994). Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263, 1618-1623.
40. Givalois L., Arancibia S., Alonso G. and Tapia-Arancibia L. (2004). Expression of brain-derived neurotrophic factor and its receptors in the median eminence cells with sensitivity to stress. Endocrinology 145, 4737-4747.
41. Givalois L., Marmigère F., Rage F., Ixart G., Arancibia S. and Tapia- Arancibia L. (2001). Immobilization stress rapidly and differentially modulates BDNF and TrkB mRNA expression in the pituitary gland of adult male rats. Neuroendocrinology 74, 148-159.
42. Glantz P.O., Meenaghan M.A., Hyun K.H. and Wirth S.M. (1989). On the presence and localization of epidermal and nerve growth factors in human whole saliva. Acta. Odontol. Scand. 47, 287-292.
43. Gresik E.W. (1994). The granular convoluted tubule (GCT) cell of rodent submandibular glands. Micros. Res. Technol. 27, 1-24.
44. Grillon C., Duncko R., Covington M.F., Kopperman L. and Kling M.A. (2007). Acute stress potentiates anxiety in humans. Biol. Psychiatry 62, 1183-1186.
45. Hand A.R. (1980). Salivary glands. In: Bhaskar SN, editor. Orban's oral histology and embryology. Mosby. St. Louis. MO. pp 336-370.
46. Hanyu O., Yamatani K., Ikarashi T., Soda S., Maruyama S., Kamimura T., Kaneko S., Hirayama S., Suzuki K., Nakagawa O., Nawa H. and Aizawa Y. (2003). Brain-derived neurotrophic factor modulates glucagons secretion from pancreatic alpha cells: Its contribution to glucose metabolism. Diabetes Obes. Metab. 5, 27-37.
47. Hatton M.N., Loomis R.E., Levine M.J. and Tabak L.A. (1985). Masticatory lubrication. The role of carbohydrate in the lubricating property of a salivary glycoprotein-albumin complex. Biochem. J. 230, 817-820.
48. Hofman L.F. (2001). Human saliva as a diagnostic specimen. J. Nutr. 131, 1621S-1625S.
49. Hori N., Yuyama N. and Tamura K. (2004). Biting suppresses stressinduced expression of corticotrophin-releasing factor (CRF) in the rat hypothalamus. J. Dent. Res. 83, 124-128.
50. Hori N., Lee M.C., Sasaguri K., Ishii H., Kamei M., Kimoto K., Toyoda M. and Sato S. (2005). Suppression of stress-induced nNOS expression in the rat hypothalamus by biting. J. Dent. Res. 84, 624-628.
51. Hutson J.M., Niall M., Evans D. and Fowler R. (1979). Effect of salivary glands on wound contraction in mice. Nature 279, 793-795.
52. Ishizaki H., Westermark A., van Setten G. and Pyykkö I. (2000). Basic fibroblast growth factor (bFGF) in saliva-physiological and clinical implications. Acta. Otolaryngol. Suppl. 543, 193-195.
53. Kafitz K.W., Rose C.R., Thoenen H. and Konnerth A. (1999). Neurotrophin-evoked rapid excitation through TrkB receptors. Nature 401, 918-921.
54. Kanamaru Y., Kikukawa A. and Shimamura K. (2006). Salivary chromogranin-A as a marker of psychological stress during a cognitive test battery in humans. Stress 9, 127-131.
55. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M. and Bertschy G. (2005). Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol. Psychiatry 57, 1068-1072.
56. Karege F., Perret G., Bondolfi G., Schwald M., Bertschy G. and Aubry J.M. (2002). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 109, 143-148.
57. Karege F., Schwald M. and Cisse M. (2002). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 328, 261-264.
58. Kim D.J., Roh S., Kim Y., Yoon S.J., Lee H.J., Han C.S. and Kim Y.K. (2005). High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci. Lett. 388, 112-115.
59. Kim Y.K., Lee H.Y., Won S.D., Park E.Y., Lee H.Y., Lee B.H., Lee S.W., Yoon D., Han C., Kim D.J. and Choi S.H. (2007). Low plasma BDNF is associated with suicidal behavior in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 78-85.
60. Kirschbaum C. and Hellhammer D.H. (1994). Salivary cortisol in psychoneuroendocrine research: recent development and application. Psychoneuroendocrinology 19, 313-333.
61. Knusel B., Winslow J.W., Rosenthal A., Burton L.E., Seid D.P., Nikolics K. and Hefti F. (1991). Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. USA 88, 961-965.
62. Kodomari I., Wada E., Nakamura S. and Wada K. (2009). Maternal supply of BDNF to mouse fetal brain through the placenta. Neurochem. Int. 54, 95-98.
63. Konturek S.J., Brzozowski T., Konturek P.K., Majka J. and Dembinski A. (1991). Role of salivary glands and epidermal growth factor (EGF) in gastric secretion and mucosal integrity in rats exposed to stress. Regul. Pept. 32, 203-215.
64. Kousvelari E.E., Baratz R.S., Burke B. and Oppenheim F.G. (1980). Immunochemical identification and determination of proline-rich proteins in salivary secretions, enamel pellicle, and glandular tissue specimens. J. Dent. Res. 59, 1430-1438.
65. Kurahashi M. and Inomata K. (1999). Relationship between parotid amylase secretion and osmolality in the gastric contents of rats fed a pelleted or liquid diet. Jpn. J. Physiol. 49, 507-512.
66. Lee T., Saruta J., Sasaguri K., Sato S. and Tsukinoki K. (2008). Allowing animals to bite reverses the effects of immobilization stress on hippocampal neurotrophin expression. Brain Res. 1195, 43-49.
67. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H. and Barde Y.A. (1989). Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341, 149-152.
68. Levi-Montalcini R. (1987). The nerve growth factor 35 years later. Science 237, 1154-1162.
69. Levi-Montalcini R. and Angeletti P.U. (1968). Nerve growth factor. Physiol. Rev. 48, 534-569.
70. Lewin G.R. and Barde Y.A. (1996). Physiology of the neurotrophins. Annu. Rev. Neurosci. 19, 289-317.
71. Lipps B.V. (2000). Isolation of nerve growth factor (NGF) from human body fluids; saliva, serum and urine: comparison between cobra venom and cobra serum NGF. J. Nat. Toxins 9, 349-356.
72. Llena-Puy C. (2006). The role of saliva in maintaining oral health and as an aid to diagnosis. Med. Oral. Pathol. Oral. Cir. Bucal. 11, E499-E455.
73. Lommatzsch M., Zingler D., Schuhbaeck K., Scholetcke K., Zingler C., Schuff-Werner P. and Virchow J.C. (2005). The major of age, weight, and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging 26, 115-123.
74. Lu B. and Chow A. (1999). Neurotrophins and hippocampal synaptic transmission and plasticity. J. Neurosci. Res. 58, 76-87.
75. Lucas R.M., Ponsonby A.L. and Dear K. (2007). Mid-life stress is associated with both up- and down-regulation of markers of humoral and cellular immunity. Stress 10, 351-361.
76. Mandel A.L., Ozdener H. and Utermohlen V. (2009). Identification of pro- and mature brain-derived neurotrophic factor in human saliva. Arch. Oral. Biol. 54, 689-695.
77. Manni L., Nikolova V., Vyagova D., Chaldakov G.N. and Aloe L. (2005). Reduced plasma levels of NGF and BDNF inpatients with acute coronary syndromes. Int. J. Cardiol. 102, 169-171.
78. Mathison R., Davison J.S. and Befus A.D. (1994). Neuroendocrine regulation of inflammation and tissue repair by submandibular glands factors. Immunol. Today 15, 527-532.
79. Mese O. and Matsuo R. (2007). Salivary secretion, taste and hyposalivation. J. Oral. Rehabil. 34: 711-723.
80. Mogi M., Inagaki H., Kojima M., Minami M. and Harada M. (1995). Transforming growth factor alpha in human submandibular gland and saliva. J. Immunoassay 16, 379-394.
81. Nakahashi T., Fujimura H., Altar C.A., Li J., Kambayashi J., Tandon N.N. and Sun B. (2000). Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett. 470, 113-117.
82. Nam J.W., Chung J.W., Kho H.S., Chung S.C. and Kim Y.K. (2007). Nerve growth factor concentration in human saliva. Oral. Dis. 13, 187-192.
83. Okamura M., Yoshida A., Saruta J., Tsukinoki K., Sasaguri K. and Sato S. (2008). Effect of bruxism-like activity on the salivary chromogranin A as a stress marker. Stomatologie 105, 33-39.
84. Pang P.T., Teng H.K., Zaitsev E., Woo N.T., Sakata K., Zher S., Teng K.K., Yung W.H., Hempstead B.L. and Lu B. (2004). Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306, 487-491.
85. Pan W., Banks W.A., Fasold M.B., Bluth J. and Kastin A.J. (1998). Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37, 1553-1561.
86. Parikh V., Evans D.R., Khan M.M. and Mahadik S.P. (2003). Nerve growth factor in nerve-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome. Schizophr. Res. 60, 117-123.
87. Pedersen A.M., Bardow A., Jensen S.B. and Nauntofte B. (2002). Saliva and gastrointestinal functions of taste, mastication, swallowing and digestion. Oral. Dis. 8, 117-129.
88. Pinnock S.B., Balendra R., Chan M., Hunt L.T., Turner-Stokes T. and Herbert J. (2007). Interactions between nitric oxide and corticosterone in the regulation of progenitor cell proliferation in the dentate gyrus of the adult rat. Neuropsychopharmacology 32, 493-504.
89. Raap U., Goltz C., Deneka N., Bruder M., Renz H., Kapp A. and Wedi B. (1999). Brain-derived neurotrophic factor is increased in atophic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. J. Allergy Clin. Immunol. 115, 1268-1275.
90. Radecki D.T., Brown L.M., Martinez J. and Teyler T.J. (2005). BDNF protects against stress-induced impairments in spatial learning and memory and LTP. Hippocampus 15, 246-253.
91. Radka S.F., Holst P.A., Fritsche M. and Altar C.A. (1996). Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay. Brain. Res. 709, 122-130.
92. Rost B., Hanf G., Ohnemus U., Otto-Knapp R., Groneberg D.A., Kunkel G. and Noga O. (2005). Monocytes of allergics and non-allergics produce, store, and release the neurotrophins NGF, BDNF, and NT- 3. Regul. Pept. 124, 19-25.
93. Ruhl S., Hamberger S., Betz R., Sukkar T., Schmalz G., Seymour R.A., Hiller K.A. and Thomason J.M. (2004). Salivary proteins and cytokines in drug-induced gingival overgrowth. J. Dent. Res. 83, 322-326.
94. Saruta J., Tsukinoki K., Sasaguri K., Ishii H., Yasuda M., Osamura Y.O., Wtanabe Y. and Sato S. (2005). Expression and localization of Chromogranin A gene and protein in human submandibular. Cells Tissues Organs 180, 237-244.
95. Saruta J., Lee T., Shirasu M., Takahashi T., Sato C., Sato S. and Tsukinoki K. (2010). Chronic stress affects the expression of BDNF in rat submandibular glands. Stress 13, 53-60.
96. Saruta J., Kondo Y., Sato C., Shiiki N., Tsukinoki K. and Sato S. (2010). Salivary glands as the source of plasma BDNF in stressed rats engaged in biting behavior. Stress (in press).
97. Schuhman B., Dietrich A., Sel S., Hahn C., Klingenspor M., Lommatzsch M., Gudermann T., Braun A., Renz H. and Nockher W.A. (2005). A role brain-derived neurotrophic factor in B cell development. J. Neuroimmunol. 163, 15-23.
98. Schwab K.O., Heubel G. and Bartels H. (1992). Free epinephrine, norepinephrine and dopamine in saliva and plasma of healthy adults. Eur. J. Clin. Chem. Clin. Biochem. 30, 541-544.
99. Shibayama E. and Koizumi H. (1996). Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am. J. Pathol. 148, 1807-1818.
100. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S. and Iyo M. (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 54, 70-75.
101. Slowey P.R., Eidelman S. and Klebanoff S.J. (1968). Antibacterial activity of the purified peroxidase from human parotid saliva. J. Bacteriol. 96, 575-579.
102. Sobue G., Yamamoto M., Doyu M., Li M., Yasuda T. and Mitsuma T. (1998). Expression of mRNAs for neurotrophins (NGF, BDNF, and NT-3) and their receptors (p75 NGFR, trk, trkB, and trkC) in human peripheral neuropathies. Neurochem. Res. 23, 821-829.
103. Sreebny L.M. (1987). The salivary system. In: Salivary electrolytes and fluid protection in health and disease. CRC Press. Boca Raton, Florida. pp 95-122.
104. Streeten D.H., Anderson G.H., Dalakos T.G., Seeley D., Mallov J.S., Eusebio R., Sunderlin F.S., Badawy S.Z. and King R.B. (1984). Normal and abnormal function of the hypothalamic-pituitaryadrenocortical system in man. Endocr. Rev. 5, 371-394.
105. Taichman N.S., Cruchley A.T., Fletcher L.M., Hagi-Pavli E.P., Paleolog E.M., Abrams W.R., Booth V., Edwards R.M. and Malamud D. (1998). Vascular endothelial growth factor in normal human salivary glands and saliva: a possible role in the maintenance of mucosal homeostasis. Lab. Invest. 78, 869-875.
106. Takai N., Yamaguchi M., Aragaki T., Eto K., Uchihashi K. and Nishikawa Y. (2004). Effect of psychological stress on the salivary cortisol and amylase levels in healthy young adult. Arch. Oral. Biol. 49, 963-968.
107. Tan Y.L., Zhou D.F. and Zhang X.Y. (2005). Decreased plasma brainderived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizoph. Res. 74, 263-270.
108. Tenovuo J. and Knuuttila M.L. (1977). Antibacterial effect of salivary peroxidases on a cariogenic strain of streptococcus mutans. J. Dent. Res. 56, 1608-1613.
109. Timmusk T., Palm K., Metsis M., Reintam T., Paalme V., Saarma M. and Persson H. (1993). Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10, 475-489.
110. Tirassa P., Manni L., Stenfors C., Lundeberg T. and Aloe L. (2000). RTPCR ELISA method for the analysis of neurotrophin mRNA expression in brain and peripheral tissues. J. Biotechnol. 84, 259-272.
111. Toda M. and Morimoto K. (2008). Effect of lavender aroma on salivary endocrinological stress marker. Arch. Oral. Biol. 53, 964-968.
112. Toda M., Den R., Nagasawa S., Kitamura K. and Morimoto K. (2005). Relationship between lifestyle scores and salivary stress markers cortisol and chromogranin A. Arch. Environ. Occup. Health. 60, 266-269.
113. Toyooka K., Asama K., Watanabe Y., Muratake T., Takahashi M., Someya T. and Nawa H. (2002). Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients. Psychiatry Res. 110, 249-257.
114. Troxler R.F., Offner G.D., Xu T., Vanderspek J.C. and Oppenheim F.G. (1990). Structural relationship between human salivary histatins. J. Dent. Res. 69, 2-6.
115. Tsukinoki K., Yasuda M., Asano S., Karakida K., Ota Y., Osamura R.Y. and Watanabe Y. (2003). Association of hepatocyte growth factor expression with salivary gland tumor differentiation. Pathol. Int. 53, 815-822.
116. Tsukinoki K., Yasuda M., Miyoshi Y., Mori Y., Ootsuru M., Saruta J., Sato S., Kaneko A., Watanabe Y. and Osamura Y. (2005). Role of hepatocyte growth factor and c-Met receptor in neoplastic conditions of salivary glands. Acta Histochem. Cytochem. 38, 25-30.
117. Tsukinoki K., Saruta J., Sasaguri K., Miyoshi Y., Jinbu Y., Kusama M., Sato S. and Watanabe Y. (2006). Immobilization stress induces BDNF in rat submandibular glands. J. Dent. Res. 85, 844-848.
118. Tsukinoki K., Saruta J., Muto N., Sasaguri K., Sato S., Tan-Ishii N. and Watanabe Y. (2007). Submandibular glands contribute to increases in plasma BDNF levels. J. Dent. Res. 86, 260-264.
119. Turner R.J. and Sugiya H. (2002). Understanding salivary fluid and protein secretion. Oral. Dis. 8, 3-11.
120. Ueyama T., Kawai Y., Nemoto K., Sekimoto M., Tone S. and Senba E.(1997). Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci. Res. 28, 103-110.
121. van Stegeren A., Rohleder N., Everaerd W. and Wolf O.T. (2006). Salivary alpha-amylase as marker for adrenergic activity during stress: Effect of betablockade. Psychoneuroendocrinology 31, 137-141.
122. van Stegeren A., Wolf O.T. and Kindt M. (2008). Salivary alpha amylase and cortisol responses to different stress tasks: Impack of sex. Int. J. Psychophysiol. 69, 33-40.
123. Watson A.Y., Anderson J.K., Siminoski K., Mole J.E. and Murphy R.A. (1985). Cellular and subcellular colocalization of nerve growth factor and epidermal growth factor in mouse submandibular glands. Anat. Rec. 213, 365-376.
124. Yamamoto H. and Gurney M.E. (1990). Human platelets contain brainderived neurotrophic factor. J. Neurosci. 10, 3469-3478.